Disease/Infection News

RSS

Discovering new natural products from human microbiomes

The idea of using microorganisms as a source of new active ingredients is not new. Numerous drugs have already been developed on the basis of natural products from bacteria and fungi.

17 Oct 2024

Georgetown University receives $27.5 million grant to combat HIV/AIDS in Haiti

The U.S. Centers for Disease Control and Prevention (CDC) and the President's Emergency Plan for AIDS Relief (PEPFAR), have awarded $27.5 million to the Center for Global Health Practice and Impact (CGHPI) at Georgetown University Medical Center to expand its ongoing work in Haiti to address HIV/AIDS.

17 Oct 2024

U.S. cancer detection severely disrupted during first year of COVID-19, shows incomplete recovery in second year

A JAMA study finds COVID-19 caused a 127,931 deficit in cancer diagnoses in 2020, with recovery in 2021 influenced by demographic and community characteristics.

17 Oct 2024

UF Health scientists receive major grant to combat antibiotic-resistant bacteria

University of Florida Health scientists exploring how combinations of antibiotics can fight resistant bacteria have been awarded an $11.8 million grant for work that could help save the tens of thousands of lives lost yearly to infections that are increasingly plaguing humanity.

17 Oct 2024

COVID study shows higher risk for those with multiple illnesses

Individuals with multiple long-term conditions are two and a half times more likely to die following COVID-19 infection than others. When children were assessed separately the risk for mortality among those with multiple long-term conditions increased to almost three times (2.8) the risk of those without. The mortality rates are 22% and 8% respectively.

17 Oct 2024

A deeper look at COVID-19 transmission and fetal health

A new Cleveland Clinic-led study published in The EMBO Journal shows that mild and asymptomatic SARS-CoV-2 infections can trigger immune responses in a pregnant individual that may cause serious inflammatory responses in the developing fetus.

17 Oct 2024

Genetic analysis shows smoking and high BMI increase dementia risk, but education and exercise protect

Mendelian randomization of 400,000 participants reveals smoking, high BMI, and high cholesterol as major genetic risk factors for dementia, while longer education and physical activity reduce risks.

17 Oct 2024

Electronic nudges improve flu vaccination rates in non-diabetic patients but fail to increase uptake in diabetics

Electronic nudges had a small impact on flu vaccine uptake in patients without diabetes but showed no significant effect among diabetic patients, suggesting the need for tailored strategies for this group.

16 Oct 2024

Study shows safety of kidney transplants among those with HIV infections

It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are also HIV positive as it is from donors who are not infected with the virus, a new study shows.

16 Oct 2024

WHO confirms elimination of trachoma in South Asia

The world moved closer to eliminating trachoma this month after the World Health Organization (WHO) confirmed India and Pakistan as being free of the disease, a leading cause of blindness.

16 Oct 2024

Shift Bioscience raises $16 M to advance cell simulation AI platform

Shift Bioscience is a biotech company using generative AI models to understand how activation of different genes can reverse the aging process. This research is a fundamental step forward in designing more effective drugs to treat age-related diseases.

From Shift Bioscience 16 Oct 2024

Genetic risk factors for long-COVID uncovered in a large multi-ethnic study

Researchers identified genetic loci and phenotypes linked to long-COVID in the largest multi-ethnic GWAS, revealing increased risk factors for chronic conditions like fatigue, depression, and fibromyalgia.

16 Oct 2024

Antibody engineering drives innovation in drug development

Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market for mAbs has grown exponentially with an expected compound annual growth rate (CAGR) of 11.07% from 2024 (237.64 billion USD estimated at the end of 2023) to 2033 (679.03 billion USD expected by the end of 2033).

16 Oct 2024

COVID-19 raises the risk of type 2 diabetes in children, study reveals

Researchers found that children who contracted COVID-19 were at a higher risk of developing type 2 diabetes within six months, compared to those with other respiratory infections.

15 Oct 2024

New insights into pain mechanisms related to viral infections

An article published in the journal Brain, Behavior, and Immunity reports the findings of a study by researchers based in Brazil, the United States and South Korea who set out to understand how viral infections cause pain and to contribute to the search for novel ways of relieving it.

15 Oct 2024

Study shows no developmental delays in toddlers post-COVID-19 infection

Study explored the relationship between SARS-CoV-2 infection in children under two years old and cognitive development, finding no evidence of increased developmental delays post-infection. Differences in socioeconomic status were noted between COVID-19 positive and negative groups.

15 Oct 2024